Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

1910 ARTíCULOS , VIENDO DEL 91 AL 105

PUBMED

How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study.

Pregeljc D, Teodorescu-Perijoc D, Vianello R, Umek N, Mavri J.

Neurotox Res. 2020 Mar;37(3):724-731. doi: 10.1007/s12640-019-00149-0. Epub 2019 Dec 11.

0

0

0

PUBMED

No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease.

Kim JJ, Bandres-Ciga S, Blauwendraat C; International Parkinson's Disease Genomics Consortium., Gan-Or Z.

Neurobiol Aging. 2020 Mar;87:140.e19-140.e22. doi: 10.1016/j.neurobiolaging.2019.11.006. Epub 2019 Nov 14.

0

0

0

PUBMED

Neuroprotective effects of Bacopa monnieri in Parkinson's disease model.

Singh B, Pandey S, Rumman M, Mahdi AA.

Metab Brain Dis. 2020 Mar;35(3):517-525. doi: 10.1007/s11011-019-00526-w. Epub 2019 Dec 13.

0

0

0

PUBMED

Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats.

Tseng HC, Wang MH, Chang KC, Soung HS, Fang CH, Lin YW, Li KY, Yang CC, Tsai CC.

Neurotox Res. 2020 Mar;37(3):669-682. doi: 10.1007/s12640-019-00143-6. Epub 2019 Dec 6.

0

0

0

PUBMED

Association of RIT2 and RAB7L1 with Parkinson's disease: a case-control study in a Taiwanese cohort and a meta-analysis in Asian populations.

Liu TW, Wu YR, Chen YC, Fung HC, Chen CM.

Neurobiol Aging. 2020 Mar;87:140.e5-140.e11. doi: 10.1016/j.neurobiolaging.2019.11.001. Epub 2019 Nov 9.

0

0

0

PUBMED

Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence.

Morales-Briceño H, Mohammad SS, Post B, Fois AF, Dale RC, Tchan M, Fung VSC.

Brain. 2020 Mar 1;143(3):751-770. doi: 10.1093/brain/awz345.

0

0

0

PUBMED

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease.

Henderson MX, Covell DJ, Chung CH, Pitkin RM, Sandler RM, Decker SC, Riddle DM, Zhang B, Gathagan RJ, James MJ, Trojanowski JQ, Brunden KR, Lee VMY, Luk KC.

Neurobiol Dis. 2020 Mar;136:104712. doi: 10.1016/j.nbd.2019.104712. Epub 2019 Dec 16.

0

0

0

PUBMED

G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice.

Arbez N, He X, Huang Y, Ren M, Liang Y, Nucifora FC, Wang X, Pei Z, Tessarolo L, Smith WW, Ross CA.

Hum Mol Genet. 2020 Mar 13;29(4):580-590. doi: 10.1093/hmg/ddz271.

0

0

0

PUBMED

The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis.

Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR, Eastell R.

Bone. 2020 Mar;132:115173. doi: 10.1016/j.bone.2019.115173. Epub 2019 Nov 29.

0

0

0

PUBMED

NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.

Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Singh SP.

Neurotox Res. 2020 Mar;37(3):491-507. doi: 10.1007/s12640-019-00147-2. Epub 2019 Dec 10. Review.

0

0

0

PUBMED

Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.

Cressatti M, Juwara L, Galindez JM, Velly AM, Nkurunziza ES, Marier S, Canie O, Gornistky M, Schipper HM.

Mov Disord. 2020 Mar;35(3):468-477. doi: 10.1002/mds.27935. Epub 2019 Dec 4.

0

0

0

PUBMED

Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.

Li J, Gu C, Zhu M, Li D, Chen L, Zhu X.

Psychogeriatrics. 2020 Mar;20(2):180-188. doi: 10.1111/psyg.12483. Epub 2019 Dec 11.

0

0

0

PUBMED

The role of virtual reality on outcomes in rehabilitation of Parkinson's disease: meta-analysis and systematic review in 1031 participants.

Triegaardt J, Han TS, Sada C, Sharma S, Sharma P.

Neurol Sci. 2020 Mar;41(3):529-536. doi: 10.1007/s10072-019-04144-3. Epub 2019 Dec 6. Review. Erratum in: Neurol Sci. 2020 Jan 3;:.

0

0

0

PUBMED

Improvement of oral function and hygiene in Parkinson's disease: A randomised controlled clinical trial.

Baram S, Karlsborg M, Bakke M.

J Oral Rehabil. 2020 Mar;47(3):370-376. doi: 10.1111/joor.12924. Epub 2020 Jan 5.

0

0

0

PUBMED

Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221.

Salama RM, Abdel-Latif GA, Abbas SS, El Magdoub HM, Schaalan MF.

Neuropharmacology. 2020 Mar 1;164:107900. doi: 10.1016/j.neuropharm.2019.107900. Epub 2019 Dec 5.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy